In cases of skin cancer that are associated with overproduction of EGFR, treatment with antibodies against the extracellular portion of EGFR has been successful. Propose a model to explain how the antibody therapy most likely interferes with the cell signaling pathway, and give ONE reason the therapy is effective for treating cancer